Please turn JavaScript on
header-image

Supply Chain Management Review

Subscribe in seconds and receive Supply Chain Management Review's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.

You can select the updates using tags or topics and you can add as many websites to your feed as you like.

And the service is entirely free!

Follow Supply Chain Management Review: Error 404 (Not Found)!!1

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.02 / day

Message History

Executive takeaways Demand–supply balance is the foundation of effective planning. At its core, supply chain planning aims to ensure that demand forecasts match available supply capacity, creating operational stability and enabling organizations to fulfill orders without excessive costs or disruption. Imbalances trigger costly operational “heroi...

Read full story
Executive takeaways Cargo theft is evolving from opportunistic crime to organized fraud. Traditional “theft at rest” is increasingly being replaced by sophisticated schemes involving fake carriers and shell companies that infiltrate freight networks before disappearing with loads. Carrier vetting must become continuous, not a one-time check.

Read full story
Executive takeaways Over-customization increases long-term risk. Bespoke warehouse automation solutions often appear attractive because they match current operations, but heavy customization increases project complexity, implementation timelines, and maintenance costs. Modular automation delivers flexibility and scalability. A “Lego-blo...

Read full story

Executive takeaways The “AI pilot trap” is slowing real adoption. Many organizations launch proof-of-concept AI projects but struggle to scale them into operational use because they start with technology instead of clearly defined workflow problems. AI works best where unstructured data blocks automation.

Read full story
Executive takeaways The pharmaceutical supply chain operates on a global and fragile network. Many active pharmaceutical ingredients (APIs) and key chemical components are produced primarily in China and India, creating geographic concentration risk and exposing drug supply to geopolitical tensions, trade restrictions, and pandemic disruptions. ...

Read full story